The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
    1. About this group
    2. Reviews
      1. Aclidinium bromide for stable chronic obstructive pulmonary diseaseReview
      2. Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary diseaseReview
      3. Acupuncture for chronic asthmaReview
      4. Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthmaReview
      5. Addition of anti-leukotriene agents to inhaled corticosteroids in children with persistent asthmaReview
      6. Addition of intravenous aminophylline to inhaled beta2-agonists in adults with acute asthmaReview
      7. Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthmaReview
      8. Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in childrenReview
      9. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenReview
      10. Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenReview
      11. Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaReview
      12. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthmaReview
      13. Adenotonsillectomy for obstructive sleep apnoea in childrenReview
      14. Airway clearance techniques for bronchiectasisReview
      15. Airway clearance techniques for chronic obstructive pulmonary diseaseReview
      16. Alexander technique for chronic asthmaReview
      17. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at restReview
      18. Anti-histamines for prolonged non-specific cough in childrenReview
      19. Anti-inflammatory medications for obstructive sleep apnea in childrenReview
      20. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenReviewComment
      21. Antibiotics for acute asthmaReview
      22. Antibiotics for exacerbations of chronic obstructive pulmonary diseaseReview
      23. Antibiotics for persistent cough or wheeze following acute bronchiolitis in childrenReview
      24. Antibiotics for prolonged moist cough in childrenReview
      25. Anticholinergic agents for chronic asthma in adultsReview
      26. Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary diseaseReview
      27. Anticholinergic drugs for wheeze in children under the age of two yearsReview
      28. Anticholinergic therapy for acute asthma in childrenReview
      29. Anticholinergic therapy for bronchiectasisReview
      30. Anticholinergic therapy for chronic asthma in children over two years of ageReview
      31. Anticholinergics for prolonged non-specific cough in childrenReview
      32. Anticoagulation therapy versus placebo for pulmonary hypertensionReview
      33. Azathioprine as an oral corticosteroid sparing agent for asthmaReview
      34. Azoles for allergic bronchopulmonary aspergillosis associated with asthmaReview
      35. Beclometasone for chronic obstructive pulmonary diseaseReview
      36. Beclomethasone at different doses for chronic asthmaReview
      37. Beclomethasone for asthma in children: effects on linear growthReview
      38. Beclomethasone versus budesonide for chronic asthmaReviewComment
      39. Beclomethasone versus placebo for chronic asthmaReview
      40. Beta2-agonists for exercise-induced asthmaReview
      41. Breathing exercises for adults with asthmaReview
      42. Breathing exercises for chronic obstructive pulmonary diseaseReview
      43. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adultsReview
      44. Breathing exercises for dysfunctional breathing/hyperventilation syndrome in childrenReview
      45. Bronchial thermoplasty for moderate or severe persistent asthma in adultsReview
      46. Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasisReviewWithdrawn
      47. Budesonide at different doses for chronic asthmaReview
      48. Budesonide versus placebo for chronic asthma in children and adultsReview
      49. Caffeine for asthmaReview
      50. Calorie controlled diet for chronic asthmaReview
      51. Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary diseaseReview
      52. Cardioselective beta-blockers for chronic obstructive pulmonary diseaseReview
      53. Cardioselective beta-blockers for reversible airway diseaseReview
      54. Chloroquine as a steroid sparing agent for asthmaReview
      55. Ciclesonide versus other inhaled corticosteroids for chronic asthma in childrenReview
      56. Ciclesonide versus other inhaled steroids for chronic asthma in children and adultsReview
      57. Ciclesonide versus placebo for chronic asthma in adults and childrenReview
      58. Clinical pathways for chronic cough in childrenReview
      59. Colchicine as an oral corticosteroid sparing agent for asthmaReview
      60. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and childrenReview
      61. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and childrenReview
      62. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and childrenReview
      63. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and childrenReview
      64. Combination inhaled corticosteroids and long-acting beta2-agonists for children and adults with bronchiectasisReview
      65. Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary diseaseReview
      66. Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary diseaseReview
      67. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseReview
      68. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseReview
      69. Combined corticosteroid and long-acting beta2-agonist in one inhaler versus placebo for chronic obstructive pulmonary diseaseReview
      70. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in childrenReview
      71. Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in childrenReview
      72. Continuous positive airway pressure delivery interfaces for obstructive sleep apnoeaReview
      73. Continuous positive airways pressure for obstructive sleep apnoea in adultsReview
      74. Continuous versus intermittent beta-agonists for acute asthmaReview
      75. Corticosteroids for acute severe asthma in hospitalised patientsReview
      76. Corticosteroids for hospitalised children with acute asthmaReview
      77. Corticosteroids for idiopathic pulmonary fibrosisReview
      78. Corticosteroids for preventing relapse following acute exacerbations of asthmaReview
      79. Corticosteroids for pulmonary sarcoidosisReview
      80. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adultsReview
      81. Cow's milk protein avoidance and development of childhood wheeze in children with a family history of atopyReviewWithdrawn
      82. Culture-specific programs for children and adults from minority groups who have asthmaReview
      83. Cyclosporin as an oral corticosteroid sparing agent in stable asthmaReview
      84. Dapsone as an oral corticosteroid sparing agent for asthmaReview
      85. Dehumidifiers for chronic asthmaReview
      86. Dietary marine fatty acids (fish oil) for asthma in adults and childrenReview
      87. Dietary sodium manipulation and asthmaReview
      88. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseReviewNew Search
      89. Domiciliary oxygen for chronic obstructive pulmonary diseaseReview
      90. Domiciliary oxygen for interstitial lung diseaseReview
      91. Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary diseaseReview
      92. Drug therapy for obstructive sleep apnoea in adultsReview
      93. Early emergency department treatment of acute asthma with systemic corticosteroidsReview
      94. Early use of inhaled corticosteroids in the emergency department treatment of acute asthmaReview
      95. Education interventions for adults who attend the emergency room for acute asthmaReview
      96. Educational interventions for asthma in childrenReview
      97. Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines in adults with obstructive sleep apnoeaReview
      98. The effect of adding inhaled corticosteroids to tiotropium and long-acting beta2-agonists for chronic obstructive pulmonary diseaseReview
      99. Endothelin receptor antagonists for pulmonary arterial hypertensionReview
      100. Family therapy for asthma in childrenReview
      101. Feather versus non-feather bedding for asthmaReview
      102. Fluticasone at different doses for chronic asthma in adults and childrenReview
      103. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and childrenReview
      104. Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and childrenReview
      105. Fluticasone versus placebo for chronic asthma in adults and childrenReview
      106. Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthmaReview
      107. Galactomannan detection for invasive aspergillosis in immunocompromized patientsReviewDiagnostic
      108. Gastro-oesophageal reflux treatment for asthma in adults and childrenReview
      109. Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adultsReview
      110. Gold as an oral corticosteroid sparing agent in stable asthmaReview
      111. Heliox for non-intubated acute asthma patientsReview
      112. Heliox for treatment of exacerbations of chronic obstructive pulmonary diseaseReview
      113. Herbal interventions for chronic asthma in adults and childrenReview
      114. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and childrenReview
      115. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthmaReview
      116. Holding chambers versus nebulisers for inhaled steroids in chronic asthmaReview
      117. Home-based educational interventions for children with asthmaReview
      118. Home care by outreach nursing for chronic obstructive pulmonary diseaseReview
      119. Homeopathy for chronic asthmaReview
      120. Honey and lozenges for children with non-specific coughReview
      121. Hospital at home for acute exacerbations of chronic obstructive pulmonary diseaseReview
      122. House dust mite control measures for asthmaReview
      123. Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosisReview
      124. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and childrenReview
      125. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary diseaseReviewNew
      126. Indigenous healthcare worker involvement for Indigenous adults and children with asthmaReview
      127. Indoor air modification interventions for prolonged non-specific cough in childrenReview
      128. Influenza vaccine for children and adults with bronchiectasisReview
      129. Influenza vaccine for patients with chronic obstructive pulmonary diseaseReview
      130. Inhaled anticholinergics and short-acting beta2-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospitalReview
      131. Inhaled beta2-agonists for asthma in mechanically ventilated patientsReview
      132. Inhaled beta2-agonists for non-specific chronic cough in childrenReview
      133. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary diseaseReview
      134. Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstrictionReview
      135. Inhaled corticosteroids for non-specific chronic cough in childrenReview
      136. Inhaled corticosteroids for stable chronic obstructive pulmonary diseaseReview
      137. Inhaled corticosteroids for subacute and chronic cough in adultsReview
      138. Inhaled corticosteroids for subacute cough in childrenReview
      139. Inhaled corticosteroids in children with persistent asthma: dose-response effects on growthReview
      140. Inhaled corticosteroids in children with persistent asthma: effects on growthReview
      141. Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary diseaseReview
      142. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthmaReview
      143. Inhaled cromones for prolonged non-specific cough in childrenReview
      144. Inhaled hyperosmolar agents for bronchiectasisReview
      145. Inhaled magnesium sulfate in the treatment of acute asthmaReview
      146. Inhaled non-steroid anti-inflammatories for children and adults with bronchiectasisReview
      147. Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatmentReview
      148. Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary diseaseReview
      149. Inhaled sodium cromoglycate for asthma in childrenReview
      150. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseReview
      151. Inhaled steroids for acute asthma following emergency department dischargeReview
      152. Inhaled steroids for bronchiectasisReview
      153. Inhaled steroids for episodic viral wheeze of childhoodReview
      154. Inhaled versus oral steroids for adults with chronic asthmaReview
      155. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary diseaseReview
      156. Injection allergen immunotherapy for asthmaReview
      157. Inspiratory muscle training for asthmaReview
      158. Integrated disease management interventions for patients with chronic obstructive pulmonary diseaseReview
      159. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsReview
      160. Interventions for educating children who are at risk of asthma-related emergency department attendanceReview
      161. Interventions for primary (intrinsic) tracheomalacia in childrenReview
      162. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyemaReview
      163. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitisReview
      164. Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilatorsReview
      165. Intravenous beta2-agonists for acute asthma in the emergency departmentReview
      166. Intravenous beta2-agonists versus intravenous aminophylline for acute asthmaReview
      167. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency departmentReview
      168. Ionisers for chronic asthmaReview
      169. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary diseaseReview
      170. Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary diseaseReview
      171. Ketamine for management of acute exacerbations of asthma in childrenReview
      172. Ketotifen alone or as additional medication for long-term control of asthma and wheeze in childrenReview
      173. Leukotriene receptor antagonist for prolonged non-specific cough in childrenReview
      174. Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasisReview
      175. Leukotriene receptor antagonists in addition to usual care for acute asthma in adults and childrenReview
      176. Lifestyle modification for obstructive sleep apnoeaReview
      177. Limited (information only) patient education programs for adults with asthmaReview
      178. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary diseaseReview
      179. Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and childrenReview
      180. Long-acting beta2-agonists for bronchiectasisReview
      181. Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidReview
      182. Long-acting beta2-agonists for chronic obstructive pulmonary diseaseReview
      183. Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary diseaseReview
      184. Long-acting beta2-agonists versus theophylline for maintenance treatment of asthmaReview
      185. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisReview
      186. Lung volume reduction surgery for diffuse emphysemaReview
      187. Macrolides for chronic asthmaReview
      188. Magnesium sulfate for treating exacerbations of acute asthma in the emergency departmentReview
      189. Manual therapy for asthmaReview
      190. Mast-cell stabilising agents to prevent exercise-induced bronchoconstrictionReview
      191. Methotrexate as a steroid sparing agent for asthma in adultsReview
      192. Methylxanthines for exacerbations of chronic obstructive pulmonary diseaseReview
      193. Methylxanthines for prolonged non-specific cough in childrenReview
      194. Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthmaReview
      195. Monosodium glutamate avoidance for chronic asthma in adults and childrenReview
      196. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseReview
      197. Mucolytics for bronchiectasisReview
      198. Nebulised morphine for severe interstitial lung diseaseReview
      199. Nedocromil sodium for chronic asthma in childrenReview
      200. Nedocromil sodium for preventing exercise-induced bronchoconstrictionReview
      201. Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstrictionReview
      202. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary diseaseReview
      203. Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary diseaseReview
      204. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthmaReview
      205. Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary diseaseReview
      206. Non-pharmaceutical management of respiratory morbidity in children with severe global developmental delayReview
      207. Non-steroid agents for idiopathic pulmonary fibrosisReview
      208. Nurse specialist care for bronchiectasisReview
      209. Nurse versus physician-led care for the management of asthmaReview
      210. Nutritional supplementation for stable chronic obstructive pulmonary diseaseReview
      211. Omalizumab for asthma in adults and childrenReview
      212. Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary diseaseReview
      213. Options for self-management education for adults with asthmaReview
      214. Oral appliances for obstructive sleep apnoeaReview
      215. Oral corticosteroids for bronchiectasis (stable and acute exacerbations)Review
      216. Oral corticosteroids for stable chronic obstructive pulmonary diseaseReview
      217. Oral methylxanthines for bronchiectasisReview
      218. Oral non steroid anti-inflammatories for children and adults with bronchiectasisReview
      219. Oral theophylline for chronic obstructive pulmonary diseaseReview
      220. Oral xanthines as maintenance treatment for asthma in childrenReview
      221. Oxatomide for stable asthma in adults and childrenReview
      222. Oxygen therapy during exercise training in chronic obstructive pulmonary diseaseReview
      223. Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary diseaseReview
      224. Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in childrenReview
      225. Pet allergen control measures for allergic asthma in children and adultsReview
      226. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary diseaseReview
      227. Phosphodiesterase 5 inhibitors for pulmonary hypertensionReview
      228. Physical training for asthmaReview
      229. Physical training for bronchiectasisReview
      230. Pneumococcal vaccine for asthmaReview
      231. Pneumococcal vaccines for children and adults with bronchiectasisReview
      232. Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoeaReview
      233. Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthmaReview
      234. Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary diseaseReview
      235. Primary care based clinics for asthmaReview
      236. Prolonged antibiotics for purulent bronchiectasis in children and adultsReview
      237. Prophylactic antibiotic therapy for chronic bronchitisReviewWithdrawn
      238. Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)Review
      239. Prostacyclin for pulmonary hypertension in adultsReview
      240. Psychological interventions for adults with asthmaReview
      241. Psychological interventions for children with asthmaReview
      242. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary diseaseReview
      243. Pulmonary rehabilitation for chronic obstructive pulmonary diseaseReview
      244. Pulmonary rehabilitation for interstitial lung diseaseReview
      245. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse eventsReview
      246. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse eventsReview
      247. Regular treatment with formoterol for chronic asthma: serious adverse eventsReview
      248. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse eventsReview
      249. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthmaReview
      250. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse eventsReview
      251. Regular treatment with salmeterol for chronic asthma: serious adverse eventsReview
      252. Restriction of oral intake of water for aspiration lung disease in childrenReview
      253. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviewsReviewOverview
      254. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviewsReviewOverview
      255. Selenium supplementation for asthmaReview
      256. Self-management education and regular practitioner review for adults with asthmaReview
      257. Self management for patients with chronic obstructive pulmonary diseaseReview
      258. Short acting beta2-agonists for bronchiectasisReview
      259. Short acting beta2-agonists for recurrent wheeze in children under two years of ageReview
      260. Short-acting beta2-agonists for stable chronic obstructive pulmonary diseaseReview
      261. Short courses of antibiotics for children and adults with bronchiectasisReview
      262. Short-term ambulatory oxygen for chronic obstructive pulmonary diseaseReview
      263. Singing for children and adults with bronchiectasisReview
      264. Smartphone and tablet self management apps for asthmaReview
      265. Smoking cessation for chronic obstructive pulmonary diseaseReview
      266. Speleotherapy for asthmaReview
      267. Surgery for obstructive sleep apnoea in adultsReview
      268. Surgery versus non-surgical treatment for bronchiectasisReview
      269. Swimming training for asthma in children and adolescents aged 18 years and underReview
      270. Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary diseaseReview
      271. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseReview
      272. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adultsReview
      273. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adultsReview
      274. Tartrazine exclusion for allergic asthmaReview
      275. Telehealthcare for asthmaReview
      276. Telehealthcare for chronic obstructive pulmonary diseaseReview
      277. Tiotropium for stable chronic obstructive pulmonary diseaseReview
      278. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseReview
      279. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseReview
      280. Tiotropium versus placebo for chronic obstructive pulmonary diseaseReview
      281. Treatment of obstructive sleep apnoea for chronic cough in childrenReview
      282. Troleandomycin as an oral corticosteroid sparing agent in stable asthmaReview
      283. Vaccines for preventing influenza in people with asthmaReview
      284. Vitamin C for asthma and exercise-induced bronchoconstrictionReview
      285. Vitamin C supplementation for asthmaReviewWithdrawn
      286. Vitamins C and E for asthma and exercise-induced bronchoconstrictionReview
      287. Water-based exercise for adults with asthmaReview
      288. Water-based exercise training for chronic obstructive pulmonary diseaseReview
      289. Weight loss interventions for chronic asthmaReview
      290. Written action plans for asthma in childrenReview
      291. Written emotional disclosure for asthmaReview
      292. Written individualised management plans for asthma in children and adultsReviewWithdrawn
    3. Protocols
      1. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthmaProtocol
      2. Asthma self management education with either regular healthcare professional review or written action plans or both in adultsProtocol
      3. Breathing exercises for children with asthmaProtocol
      4. Buteyko breathing for asthmaProtocol
      5. Calcium channel blockers for pulmonary arterial hypertensionProtocol
      6. Computer and mobile technology interventions for self management in chronic obstructive pulmonary diseaseProtocolNew
      7. Cyclophosphamide for connective tissue disease–associated interstitial lung diseaseProtocol
      8. Different systemic corticosteroid regimens for the emergency management of acute asthmaProtocol
      9. Effect of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoeaProtocol
      10. Exercise-based rehabilitation programmes for pulmonary hypertensionProtocol
      11. Exhaled nitric oxide levels to guide treatment for adults with asthmaProtocolNew
      12. Exhaled nitric oxide levels to guide treatment for children with asthmaProtocolNew
      13. Glycopyrronium bromide for chronic obstructive pulmonary diseaseProtocol
      14. Guanylate cyclase stimulators for pulmonary hypertensionProtocol
      15. Helminths for asthmaProtocol
      16. Hypoallergenic formula milk versus cow's milk for prevention of wheeze and asthma in children with a family history of atopyProtocol
      17. Inhaled beta2-agonist and anticholinergic agents for emergency management of asthma in adultsProtocol
      18. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growthProtocol
      19. Inspiratory muscle training for chronic obstructive pulmonary diseaseProtocol
      20. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adultsProtocol
      21. Interventions for bronchiectasis: an overview of Cochrane systematic reviewsProtocolOverview
      22. Interventions for enhancing adherence to treatment in adults with bronchiectasisProtocol
      23. Interventions for sexual dysfunction in people with chronic obstructive pulmonary disease (COPD)ProtocolNew
      24. Intravenous magnesium sulfate for treating children with acute asthma in the emergency departmentProtocol
      25. Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in childrenProtocol
      26. Long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus either agent alone or placebo for chronic obstructive pulmonary diseaseProtocol
      27. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthmaProtocolNew
      28. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthmaProtocolNew
      29. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS for adults with asthmaProtocol
      30. Maintenance rehabilitation for chronic obstructive pulmonary diseaseProtocol
      31. Mepolizumab versus placebo for asthmaProtocol
      32. Mycophenolate mofetil (MMF) for the treatment of connective tissue disease-associated interstitial lung disease (ILD)Protocol
      33. Neuromuscular electrostimulation for chronic obstructive pulmonary diseaseProtocol
      34. Non-pharmacological management interventions for COPD: an overview of Cochrane systematic reviewsProtocolOverview
      35. Pharmacist-led interventions for adults with asthma or COPDProtocol
      36. Positional therapy for obstructive sleep apnoeaProtocol
      37. Smoking cessation in smokers with chronic obstructive pulmonary diseaseProtocol
      38. Stopping long-acting beta2-agonists (LABA) for adults with asthma well-controlled on LABA and inhaled corticosteroidsProtocol
      39. Stopping long-acting beta2-agonists (LABA) for children with asthma well controlled on LABA and inhaled corticosteroidsProtocol
      40. Sublingual immunotherapy for asthmaProtocol
      41. Systemic steroids versus placebo for acute wheeze in preschool aged childrenProtocol
      42. Tai Chi for chronic obstructive pulmonary disease (COPD)Protocol
      43. Unsupervised exercise training versus no exercise training for chronic obstructive pulmonary diseaseProtocolNew
      44. Upper limb exercise training for COPDProtocolNew
      45. Vilanterol and fluticasone for asthmaProtocol
      46. Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adultsProtocol
      47. Yoga for asthmaProtocol
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH